Pfizer
PFE
PFE
2,400 hedge funds and large institutions have $180B invested in Pfizer in 2018 Q4 according to their latest regulatory filings, with 258 funds opening new positions, 778 increasing their positions, 1,125 reducing their positions, and 86 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more ownership
Funds ownership: →
3% less capital invested
Capital invested by funds: $185B → $180B (-$5.6B)
6% less call options, than puts
Call options by funds: $1.21B | Put options by funds: $1.28B
31% less repeat investments, than reductions
Existing positions increased: 778 | Existing positions reduced: 1,125
Holders
2,400
Holding in Top 10
327
Calls
$1.21B
Puts
$1.28B
Top Buyers
| 1 | +$1.77B | |
| 2 | +$968M | |
| 3 | +$532M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$429M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$309M |
Top Sellers
| 1 | -$721M | |
| 2 | -$554M | |
| 3 | -$356M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$298M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$257M |